Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can liver stress or disease reduce circulating T3 availability?

Yes — impaired liver function reduces peripheral T4-to-T3 conversion and clearance, typically lowering circulating T3 levels.

SupportedJune 19, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The liver is a major site of peripheral T4-to-T3 conversion and thyroid hormone clearance, so liver stress or liver disease can reduce circulating T3 availability.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states the liver is the primary site for converting T4 to active T3 and for clearing thyroid hormones, so hepatic dysfunction disrupts those processes. Mechanistically, inflammatory cytokine–mediated suppression of deiodinase activity, nutrient (selenium) deficiency, and shifts toward inactive metabolites reduce the liver’s ability to generate and maintain circulating T3 during liver stress or disease.

Verified conclusion

The liver functions as the primary hub for thyroid hormone regulation, and its health is directly linked to systemic metabolic activity. As an individual ages, the liver's ability to maintain these regulatory pathways becomes increasingly significant for overall hormonal balance.

Hepatic thyroid metabolism and clearance

The liver is responsible for approximately 70% to 80% of total thyroid hormone clearance through complex metabolic pathways.

  • Conversion: Roughly 80% of circulating T3 (the active hormone) is derived from peripheral deiodination rather than direct thyroid secretion. The liver is a dominant site for this conversion, mediated primarily by the Type 1 deiodinase (DIO1) enzyme.
  • Clearance: Beyond activation, the liver manages hormone inactivation and elimination. Hepatic UDP-glucuronosyltransferases (UGTs) facilitate the glucuronidation of T4 and T3, allowing them to be excreted via bile.

Impact of liver disease on T3 availability

Clinical research consistently demonstrates that liver stress or chronic disease leads to "low T3 syndrome," also known as non-thyroidal illness syndrome (NTIS).

  • Correlation with severity: Circulating T3 levels are inversely proportional to the severity of liver dysfunction. Studies show strong negative correlations between free T3 and liver enzymes such as ALT (r = -0.902) and AST (r = -0.946).
  • Predictive value: T3 availability often decreases in direct alignment with rising Child-Turcotte-Pugh (CTP) and MELD scores, which are used to assess the prognosis of chronic liver disease.

Mechanistic explanations

The reduction in T3 during liver stress is driven by specific molecular and inflammatory disruptions:

  • Cytokine suppression: Inflammatory cytokines such as IL-6 and TNF-α, which are elevated during hepatic stress, directly inhibit the expression and activity of the DIO1 enzyme.
  • Nutritional factors: Chronic liver disease frequently results in selenium deficiency. Because deiodinases are selenoproteins, this deficiency further impairs the liver's capacity to convert T4 into active T3.
  • Inactivation pathways: In states of stress, the liver may shift its metabolic activity toward the production of reverse T3 (rT3), an inactive isomer, further reducing the pool of available active hormone.

Bottom line

The liver is essential for both generating active T3 and clearing thyroid hormones; consequently, liver disease or significant hepatic stress disrupts this balance, typically resulting in reduced T3 availability through cytokine-mediated inhibition of conversion enzymes and impaired metabolic capacity.

References

  1. Role of hepatic deiodinases in thyroid hormone homeostasis and liver metabolism, inflammation, and fibrosis — etj.bioscientifica.com ↗
  2. Role of hepatic deiodinases in thyroid hormone homeostasis and liver metabolism, inflammation, and fibrosis — pmc.ncbi.nlm.nih.gov ↗
  3. Role of the Iodothyronine Deiodinases in the Physiology and Pathophysiology of Thyroid Hormone Action — pmc.ncbi.nlm.nih.gov ↗
  4. Defending plasma T3 is a biological priority — pmc.ncbi.nlm.nih.gov ↗
  5. Metabolism of Thyroid Hormone — semanticscholar.org ↗
  6. Role of constitutive androstane receptor in developmental toxicology: linking chemical exposure, nutrition, and disease susceptibility. — tandfonline.com ↗
  7. Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders — mdpi.com ↗
  8. Thyroid hormone and the Liver — journals.lww.com ↗
  9. Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches — wjgnet.com ↗
  10. A Study of Thyroid Dysfunction in Cirrhosis of Liver and Correlation with Severity of Liver Disease — pmc.ncbi.nlm.nih.gov ↗
  11. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. — pmc.ncbi.nlm.nih.gov ↗
  12. Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. — portlandpress.com ↗
  13. Decreased hepatic thyroid hormone signaling in systemic and liver-specific but not brain-specific accelerated aging due to DNA repair deficiency in mice — etj.bioscientifica.com ↗
  14. Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→